Smith & Nephew SNATS (NYSE:SNN) Upgraded by Wall Street Zen to Strong-Buy Rating

Smith & Nephew SNATS (NYSE:SNN) was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Sunday.

Other equities research analysts have also issued reports about the stock. Canaccord Genuity Group dropped their price objective on shares of Smith & Nephew SNATS from $36.00 to $34.00 and set a “hold” rating on the stock in a report on Tuesday, November 11th. Royal Bank Of Canada reissued an “outperform” rating on shares of Smith & Nephew SNATS in a research note on Monday, October 20th. Kepler Capital Markets raised Smith & Nephew SNATS to a “strong-buy” rating in a research report on Monday, November 17th. Sanford C. Bernstein set a $37.50 price objective on Smith & Nephew SNATS and gave the stock a “market perform” rating in a report on Tuesday, October 14th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Smith & Nephew SNATS in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $35.75.

Smith & Nephew SNATS Trading Down 0.6%

SNN opened at $32.61 on Friday. Smith & Nephew SNATS has a 12 month low of $23.69 and a 12 month high of $38.79. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.40 and a current ratio of 3.00. The company has a fifty day simple moving average of $34.43 and a 200 day simple moving average of $33.68.

Institutional Investors Weigh In On Smith & Nephew SNATS

Several institutional investors and hedge funds have recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Smith & Nephew SNATS in the 3rd quarter valued at $41,000. AlphaCore Capital LLC acquired a new position in Smith & Nephew SNATS in the second quarter valued at $44,000. Northwestern Mutual Wealth Management Co. boosted its position in shares of Smith & Nephew SNATS by 105.8% during the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 1,385 shares of the medical equipment provider’s stock valued at $50,000 after purchasing an additional 712 shares in the last quarter. Huntington National Bank boosted its holdings in shares of Smith & Nephew SNATS by 1,837.0% during the 3rd quarter. Huntington National Bank now owns 1,414 shares of the medical equipment provider’s stock worth $51,000 after buying an additional 1,341 shares in the last quarter. Finally, Banque Transatlantique SA acquired a new stake in Smith & Nephew SNATS in the first quarter worth $52,000. Institutional investors own 25.64% of the company’s stock.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.